Watch Ticker

Dynavax Technologies Corporation

Go to Dynavax Technologies Corporation Website

$10.86

0.00 (0.00%)

Live

Previous Close

$10.86

Day Range

$0 - $0

Previous Day Range

$10.77 - $11.055

Market Cap

$1.3 billion USD

Day Vol.

Previous Day Vol.

1.3 million

Currency

USD

Primary Exchange

Nasdaq

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Sns Insider - Vaccine Adjuvants Market to Reach USD 5.43 Billion by 2032 Due to Increasing Demand for Enhanced Vaccine Efficacy and Global Immunization Programs – SNS Insider

The global vaccine adjuvants market is projected to grow from USD 3.83 billion in 2024 to USD 5.43 billion by 2032, with a 4.47% CAGR, driven by increasing vaccine efficacy demands and global immunization programs.

Related tickers: GSK, NVAX, DVAX.

Read Full Article

The Brainy Insights - Liver Fibrosis Market Is Expected to Reach USD 43.98 Billion By 2030

The global liver fibrosis market is expected to grow from $17.25 billion in 2021 to $43.98 billion by 2030, driven by the increasing prevalence of liver disorders, adaptation of unhealthy lifestyles, and the rising geriatric population. The North American region dominates the market due to high healthcare expenditure and the presence of major players.

Related tickers: RHHBY, JNJ, SNY, TEVA, PFE, NVS, GSK, MRK, AZN, VRTX, BMY, CELGr, GILD, DVAX, FGEN.

Read Full Article

Trending Tickers

Please sign in to view